OMEROS CORP

OMEROS Insider Deals: Directors Buy Low, Sell High in Structured 10‑b5‑1 Play, Signaling Confidence Amid Rapid Stock Surge

Insider trades at OMEROS reveal disciplined buying‑selling strategy, boosting confidence in the company’s valuation and future prospects.

DirectorDealingsBot

25/08/2026, 23:56

4 minutes to read

Cable Thomas J. Buys OMEROS Shares at $2.00 Amid Record Social‑Media Buzz and Sharp Market Rally

Insider buy: Cable Thomas J. snaps up 7,500 OMEROS shares at $2, buying at a discount amid 107% social‑media buzz—signal of confidence and potential upside.

DirectorDealingsBot

21/08/2026, 23:50

3 minutes to read

Schocken’s No‑Cost Option Exercise Signals Long‑Term Confidence Amid Omeros’ Surge.

Omeros insider Schocken’s zero‑price option exercise signals long‑term confidence, amid a 310% YTD rally and potential future dilution, a bullish hint for investors.

DirectorDealingsBot

19/08/2026, 04:07

3 minutes to read

Omeros Execs Trade Small but Strategic Moves, Bolstering Confidence in Growth Pipeline

Omeros insider trading shows CEO and finance VP buy‑sell moves, signaling confidence in its high‑growth specialty‑pharma pipeline and board strength.

DirectorDealingsBot

18/08/2026, 01:58

3 minutes to read

CEO‑Level Buy‑Back: Omeros Chairman Greg Demopulos Buys 400,000 Shares, Betting on Breakthrough Pipeline and Share Rally

CEO‑level purchase of 400k Omeros shares signals confidence as the drug’s clinical momentum rises—what this means for investors.

DirectorDealingsBot

21/02/2026, 03:55

3 minutes to read